Anvisa Combats 'Miracle' Slimming Products and Illegal Teas in the Market

Anvisa's recent ban on medicines promising miraculous weight loss, such as 'Milagroso Ervas Mounjaro,' and 'Chá Sarapião' due to lack of registration and false claims, exposes a parallel market of unproven products that can pose risks to public health. The measure aims to protect consumers from empty promises and unregulated substances, directly impacting a market niche that capitalizes on the incessant search for quick weight control solutions. The health and wellness sector, valued in billions, often attracts fraudulent initiatives that exploit consumer vulnerability and hope, creating a cycle of distrust and potential financial and health losses. Anvisa's action occurs amidst a context of accumulated inflation, a high Selic rate, and a volatile dollar, reflecting economic uncertainties that can affect imported goods, including pharmaceutical and food ingredients. This episode echoes other recent news indicating a general negative sentiment regarding stability and regulation in the Brazilian market, with volatile stock market impacts from political investigations and geopolitical tensions. The lack of registration and 'miraculous slimming effect' claims signal a clear deviation from sanitary regulations, with aggressive marketing and unrealistic promises targeting desperate consumers. The potential risk for investors in this informal sector would be total capital loss, along with potential fines and legal processes. In the next 30 to 180 days, Anvisa is expected to intensify scrutiny on irregular products, especially those circulating online. Currency volatility may increase the cost of legitimate products, potentially creating more space for illegal competitors.